IN ADDITION to its essential role in maintaining the structure and function of many proteins, enzymes, and transcriptional factors (4) , zinc also regulates the activities of several important signaling kinases such as phosphatidylinositol 3-kinase (PI3K) (3), Akt/PKB (1), extracellular signal-regulated kinase (ERK) (1) , and glycogen synthetase kinase 3␤ (GSK-3␤) (18) . Since all these signaling kinases are involved in the mechanism underlying cardioprotection against reperfusion injury (15) , treatment of cardiac cells with zinc may lead to cardioprotection against reperfusion injury. In support, Karagulova et al. (20) documented that treatment of isolated rat hearts at reperfusion with the zinc ionophore pyrithione induces cardioprotection against reperfusion injury by preserving protein kinase C isoforms. We have demonstrated (8) that exogenous zinc protects cardiac cells from reperfusion injury by targeting the mitochondrial permeability transition pore (mPTP) through inactivation of GSK-3␤ in cardiac H9c2 cells. Furthermore, the effect of zinc on GSK-3␤ was reversed by the PI3K inhibitor LY294002, and zinc markedly enhanced Akt phosphorylation (8) . Although these results suggest that the activation of PI3K/ Akt signaling is critical for zinc-induced cardioprotection, little is known regarding the mechanism by which exogenous zinc activates Akt, as mentioned by Mocanu and Yellon (29) . Accordingly, it is intriguing to explore the mechanism underlying zinc-induced Akt activation.
PI3K/Akt signaling is modulated by various phosphatases at several levels (2) . It is regulated by the protein tyrosine phosphatase (PTPase) family at the level of receptor tyrosine kinase (RTK), lipid phosphatases such as phosphatase and tensin homolog deleted on chromosome 10 (PTEN) at the level of lipids such as phosphatidylinositol 3,4,5-trisphosphate (PIP 3 ) generated by PI3K, and Ser/Thr phosphatases that inactivate Akt by reversing phosphorylation of Thr 308 and Ser 473 . Since zinc can inhibit PTPase in rat glioma cells (14) and zinc-induced activation of the PI3K/Akt pathway is mediated by Src-dependent stimulation of the epidermal growth factor receptor (EGFR) (33) , it is possible that exogenous zinc activates RTK by suppressing PTPase, which in turn leads to activation of PI3K/Akt. PTEN is a highly conserved phosphatase and negatively regulates the PI3K/Akt signaling pathway by dephosphorylating PIP 3 to phosphatidylinositol 4,5-bisphosphate (PIP 2 ). Although PTEN is a constitutively active enzyme, its activity can be downregulated by phosphorylation or oxidation (25) . Exposure of human airway epithelial cells to zinc for a relatively long period (4 h) can induce PTEN protein degradation and loss of function (34) . However, it is unlikely that treatment of H9c2 cells with zinc for a short time (20 min) could markedly reduce PTEN protein levels in our study. Nevertheless, it is still interesting to test whether zinc rapidly downregulates PTEN activity to activate Akt. Since Ser/Thr phosphatases can inhibit Akt by dephosphorylating Thr 308 and Ser 473 residues (30) , it is worthwhile to determine whether zinc activates Akt by downregulating Ser/Thr phosphatase activities.
In this study, we first examined whether zinc could alter PTEN activity by evaluating both phosphorylation (Ser 380 / Thr 382/383 ) and the total protein levels of PTEN in cardiac H9c2 cells. We next determined whether zinc activates Akt through RTKs, focusing on the roles of insulin-like growth factor 1 receptor tyrosine kinase (IGF-1RTK) and epithelial growth factor receptor tyrosine kinase (EGFRTK). We then tested whether inhibition of IGF-1RTK can block the preventive effect of zinc on the mPTP opening. Finally, we tested whether zinc can alter Ser/Thr protein phosphatase activity.
MATERIALS AND METHODS
Cell culture. The rat heart tissue-derived H9c2 cardiac myoblast cell line was purchased from American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS) and 100 U of penicillin-streptomycin at 37°C in a humidified 5% CO 2-95% air atmosphere.
Chemicals and antibodies. ZnCl2 and pyrithione were purchased from Sigma (St. Louis, MO). LY294002, wortmannin, and genistein were obtained from LC Laboratories (Woburn, MA). Protein phosphatase (PP)2, AG1024, and AG1478 were purchased from EMS Chemicals (Gibbstown, NJ). The PP2A activity assay kit was purchased from Promega (Madison, WI). All antibodies were obtained from Cell Signaling Technology (Beverly, MA).
Western blotting analysis. Equal amounts of protein lysates (whole cell or mitochondria or cytosol) were loaded and electrophoresed on SDS-polyacrylamide gel and transfected to a polyvinylidene difluoride (PVDF) membrane. Membranes were probed with primary antibodies that recognize phosphorylation of Akt, GSK-3␤, PTEN, IGF-1 receptor (IGF-1R), Ser/Thr, and Tyr. Each primary antibody binding was detected with a secondary antibody and visualized by the enhanced chemiluminescence (ECL) method. Equal loading of samples was confirmed by reprobing membranes with anti-tubulin antibody.
Identification of reduced and oxidized forms of PTEN. The reduced and oxidized forms of PTEN were analyzed with Western blotting as previously described (22) .
Confocal imaging of mitochondrial membrane potential. Mitochondrial membrane potential (⌬⌿m) was measured with confocal ) and GSK-3␤ (Ser 9 ) phosphorylation in cardiac H9c2 cells subjected to simulated ischemia-reperfusion (I/R). ZnCl2 (10 M) and pyrithione (4 M) were given at the onset of reperfusion, and cells were collected 20 min after exposure to ZnCl2. ZnCl2 significantly increased both Akt and GSK-3␤ phosphorylation upon reperfusion. I, ischemia. microscopy as reported previously (19) . Briefly, cardiac cells cultured in a specific temperature-controlled culture dish were incubated with tetramethylrhodamine ethyl ester (TMRE, 100 nM) in standard Tyrode solution containing (mM) 140 NaCl, 6 KCl, 1 MgCl 2, 1 CaCl2, 5 HEPES, and 5.8 glucose (pH 7.4) for 10 min. Cells were then mounted on the stage of an Olympus FV 500 laser scanning confocal microscope. Red fluorescence was excited with the 543-nm line of an argon-krypton laser and imaged through a 560-nm long-path filter. Temperature was maintained at 37°C with Delta T Open Dish Systems (Bioptechs, Butler, PA). The images recorded on a computer were quantified with Image J.
PP2A activity assay. PP2A activity was determined with a Ser/Thr phosphatase assay kit (Promega) according to the manufacturer's instructions. Briefly, cell lysates (25 l) were centrifuged at 15,000 g for 1 h after a short sonication. Endogenous free phosphate was removed from the lysate supernatant with a Sephadex G-25 resin spin column. Ser/Thr phosphate activity was measured colorimetrically by the capacity to dephosphorylate a synthetic 754-Da phosphopeptide through formation of molybdate. The total Ser/Thr phosphatase activity for each sample was expressed as a percentage of the value measured in cell lysate without PP2A substrates.
Experimental protocols. Cultured cells were washed twice with Tyrode solution and then incubated in Tyrode solution for 2 h before experiments. To examine the effect of extracellular zinc on phosphorylation of kinases, receptors, and kinase residues, cells were exposed to 10 M ZnCl 2 together with 4 M zinc ionophore pyrithione for 20 min. Inhibitors were applied 20 min before exposure to ZnCl2. In the study evaluating the effect of exogenous zinc on ⌬⌿m, cells were exposed to 600 M H 2O2 for 20 min to cause mitochondrial oxidant damage. ZnCl2 (10 M) and 4 M pyrithione were given 20 min before exposure to H2O2. AG1024 was applied 20 min before exposure to ZnCl2. To test whether exogenous zinc can activate Akt and IGF-1R after ischemia, cells were exposed to a simulated ischemia solution [glucose-free Tyrode solution containing 10 mM 2-deoxy-Dglucose and 10 mM sodium dithionite (17) ] for 90 min, followed by 30 min of reperfusion with the normal Tyrode solution. ZnCl 2 (10 M) and 4 M pyrithione were applied at the onset of reperfusion for 20 min.
Statistical analysis. Data are expressed as means Ϯ SE and were obtained from at least six experiments. Statistical significance was determined by one-way ANOVA followed by Tukey's test. A value of P Ͻ 0.05 was considered as statistically significant.
RESULTS
Treatment of H9c2 cells with 10 M ZnCl 2 in the presence of the zinc ionophore pyrithione (4 M) dramatically increased Akt phosphorylation at Ser 473 , an effect that was abrogated by the Zn 2ϩ chelators ethylenediaminetetraacetic acid (EDTA, 10 mM) and N,N,NЈ,NЈ-tetrakis(2-pyridylmethyl)ethylenediamine (TPEN, 10 M), indicating that exogenous zinc can activate Akt (Fig. 1A) . ZnCl 2 also markedly increased Akt and GSK-3␤ phosphorylation upon reperfusion in cardiac cells (Fig. 1B) . To test whether zinc activates Akt through inhibition of PTEN, the negative regulator of the PI3K/Akt pathway, we determined the effect of zinc on PTEN phosphorylation at Ser 380 /Thr [382] [383] . As shown in Fig. 2A , treatment of cells with 10 M ZnCl 2 for 20 min did not alter PTEN phosphorylation, although phosphorylation of Akt and GSK-3␤ was significantly augmented by the treatment. In addition, 10 M ZnCl 2 did not alter PTEN protein levels (Fig. 2B ). Treatment of cells with H 2 O 2 resulted in the appearance of the higher-mobility form of PTEN (oxidized form) (Fig. 2C) . In contrast, cells treated with ZnCl 2 did not show this form. These results indicate that exogenous zinc may not rapidly regulate PTEN activity in H9c2 cells.
To investigate whether exogenous zinc activates Akt through RTKs, we tested effects of various RTK inhibitors on zinc-induced Akt phosphorylation. As shown in Fig. 3 , the effect of ZnCl 2 (10 M) on Akt phosphorylation at Ser 473 was significantly inhibited by genistein (100 M) (9), a nonselective RTK inhibitor, indicating that zinc may activate Akt via RTKs. Further experiments showed that the action of zinc was reversed by AG1024 (5 M) (6), a selective inhibitor of IGF-1RTK, but not by the Src tyrosine kinase inhibitor PP2 (10 M) (36) or AG1478 (10 M) (28), a selective inhibitor of EGFRTK, suggesting that exogenous zinc activates Akt through activation of IGF-1RTK (Fig. 3) .
To test whether zinc activates Akt by entering cells, we determined the role of the zinc ionophore pyrithione in the action of zinc. As shown in Fig. 4A , in the absence of pyrithione, ZnCl 2 (10 M) did not alter Akt and GSK-3␤ phosphorylation. Likewise, IGF-1R was activated by ZnCl 2 (10 M) only when cells were cotreated with pyrithione (Fig.  4B) . Pyrithione alone did not alter phosphorylation of Akt and IGF-1R (Fig. 4) . These results suggest that zinc activates Akt after entering cells.
To establish the role of IGF-1RTK in the action of zinc, we tested whether exogenous zinc can activate IGF-1RTK by measuring phosphorylation levels of IGF-1R at Tyr 1135/1136 , since phosphorylation of Tyr 1135/1136 residues is necessary for activation of IGF-1RTK (24) . As shown in Fig. 5A , ZnCl 2 (10 M) significantly increased IGF-1R phosphorylation in cardiac cells, assuring that exogenous zinc indeed activates IGF-1RTK. ZnCl 2 (10 M) also markedly enhanced IGF-1R phosphorylation in cells subjected to simulated ischemia-reperfusion (Fig. 5B) . Zinc-induced IGF-1R phosphorylation was reversed by AG1024 (5 M) and was partially inhibited by genistein (100 M) (Fig. 5C ). PP2 (10 M) and AG1478 (10 M) were not able to block the action of zinc. Genistein, PP2, AG1024, and AG1478 did not alter IGF-1R phosphorylation in the absence of Zn 2ϩ (Fig. 5C ). These results further support the essential role of IGF-1RTK in the action of zinc.
Having demonstrated the critical role of IGF-1RTK in zincinduced Akt activation, we tested whether inhibition of IGF-1RTK could reverse the preventive effect of zinc on oxidantinduced mPTP opening. As show in Fig. 6 , ZnCl 2 (10 M) prevented 600 M H 2 O 2 -induced loss of TMRE fluorescence, indicating that exogenous zinc can modulate the mPTP opening. In contrast, zinc was not able to preserve TMRE fluorescence in the presence of the IGF-1RTK inhibitor AG1024 (5 M), suggesting that IGF-1RTK contributes to the protective effect of zinc through activation of Akt.
Akt can be inactivated by dephosphorylation of Ser 473 and Thr 308 residues by Ser/Thr protein phosphatases. Thus inhibition of Ser/Thr protein phosphatases may lead to Akt activation. To test whether inactivation of Ser/Thr protein phosphatases accounts for zinc-induced Akt activation, we examined the effect of zinc on the activity of PP2A, a major Ser/Thr protein phosphatase. As shown in Fig. 7A , ZnCl 2 (10 M) decreased PP2A activity, indicating that Ser/Thr protein phosphatases may also be involved in zinc-induced Akt activation. Calyculin A (12.5 nM), a cell-permeant Ser/Thr protein phosphatase inhibitor, mimicked the effect of ZnCl 2 to increase Akt phosphorylation (Fig. 7B) .
DISCUSSION
The PI3K/Akt signaling pathway plays an essential role in protecting the heart from ischemia-reperfusion injury (16) . Recently, we have also demonstrated (8) that Akt mediates exogenous zinc-induced cardioprotection against reperfusion injury by inactivating GSK-3␤. In this study, we sought to explore the mechanism by which exogenous zinc activates Akt and found that IGF-1RTK and Ser/Thr protein phosphatases may contribute to zinc-induced Akt activation.
Many growth-promoting ligands such as insulin, IGF-1, and EGF bind to RTKs and can activate Akt (21, 35, 37) . In this study, the effect of exogenous zinc on Akt phosphorylation was blocked by the selective IGF-1RTK inhibitor AG1024 but not by the selective EGFRTK inhibitor AG1478. AG1024 also abolished the effect of zinc on phosphorylation of protein tyrosine and Ser/Thr. Moreover, zinc increased IGFR phosphorylation, and this was reversed by AG1024 but not by AG1478. Furthermore, the preventive effect of zinc on the mPTP opening was reversed by AG1024. These observations clearly suggest that IGF-1RTK but not EGFRTK is responsible for the action of zinc on Akt activity. In support, a recent report has documented that zinc can modulate IGF-1 signaling in C6 rat glioma cells by regulating PTPase activities (14) . However, our finding is inconsistent with a previous study by Wu et al. (33) reporting that zinc activates Akt via a Src-dependent stimulation of EGFR in human bronchial epithelial cells. The fact that Wu et al. treated cells with a higher dose of Zn 2ϩ (50 M) for a longer time (120 min) may explain the discrepancy. It should be mentioned that although our observations adopting the specific inhibitors and antibody clearly indicate the essential role of IGF-1R in the action of zinc, future studies with IGF-1R and EGFR mutants or small interfering RNAs (siRNAs) will help establish their role in the action of zinc.
RTKs are integral membrane proteins that have a ligandbinding domain on the extracellular side and a tyrosine kinase domain on the cytosolic side. Although little is known as to whether exogenous zinc stimulates IGF-1RTK through its binding to the ligand-binding domain on the extracellular side, our data showed that exogenous zinc failed to activate either Akt or IGF-1R in the absence of the zinc ionophore pyrithione, indicating that zinc activates IGF-1RTK by entering cells rather than by binding to the extracellular binding domain. Thus it is reasonable to speculate that zinc activates IGF-1RTK by directly or indirectly interacting with the tyrosine kinase domain on the cytosolic side. Autophosphorylation of RTKs within the kinase domain upregulates the kinase activity, and the phosphorylation state of RTKs is modulated by PTPases (11) . Zinc has been demonstrated to inhibit PTPases (5). Exogenous zinc can activate EGFR signaling by inhibiting PTPase in airway epithelial cells (31) . In addition, intracellular zinc fluctuation has also been reported to modulate insulin signaling by suppressing PTPase activity (13) . Therefore, it is likely that exogenous zinc activated IGF-1RTK through inhibition of PTPase in cardiac cells in this study. While we did not directly measure PTPase activity in the present study, our observation (see Supplemental Data) that zinc markedly enhanced tyrosine phosphorylation may imply that zinc activate IGF-1RTK by inhibiting PTPs. 1 Thus it would be intriguing to define the specific subtype (s) of PTPs that mediates the action of zinc in future studies.
PTEN is well known to negatively regulate PI3K/Akt signaling by dephosphorylating PIP 3 . Thus suppression of PTEN activity could lead to cardioprotection through activation of the PI3K/Akt pathway (25) . Indeed, it has been reported that loss of PTEN activity is responsible for induction of preconditioning in isolated rat hearts (7), although the protocol of ischemic preconditioning used in that study was questioned by other investigators (25) . The importance of PTEN in cardioprotection has also been demonstrated in a recent study showing that loss of the cardioprotective effect of atorvastatin was associated with an increase in PTEN levels in the heart (26) . Thus it is intriguing to test whether zinc activates Akt through inactivation of PTEN. Although the regulatory mechanism for PTEN activity remains unclear, phosphorylation and oxidation may deactivate PTEN (12) . In this study, we found that zinc did not alter PTEN phosphorylation, indicating that zinc may not inactivate PTEN through phosphorylation. Since PTEN is a constitutively active phosphatase, its activity also depends on its cellular level (25) . Indeed, Wu et al. (34) reported that exogenous zinc decreases PTEN protein levels through proteasomal degradation in airway epithelial cells, leading to Akt activation. However, it should be noted that PTEN degradation was prominent after a long period (4 h) of treatment with a high dose (50 M) of Zn 2ϩ (34) . In the present study, we treated cardiac cells with a low dose of zinc (10 M) for a short time (20 min) and found that zinc did not alter cellular PTEN protein levels. Thus it is unlikely that zinc upregulated Akt activity by degrading PTEN in this study. In light of these findings, PTEN may not play an important role in zinc-induced Akt activation in this study in which cardiac cells experienced a short exposure to zinc. However, it is still possible that zinc may activate Akt by decreasing PTEN protein levels with longer treatments. Since PTEN is also reversibly inactivated through oxidation (23), we further tested whether zinc could inactivate PTEN by oxidizing it. Our data exclude the possibility that zinc may inhibit PTEN through oxidation in cardiac cells.
Akt is activated by PDK-dependent phosphorylation of Ser 473 and Thr 308 residues (32) . Dephosphorylation of the two residues by Ser/Thr protein phosphatases can inactivate Akt (2, 27) . Therefore, it is not surprising that inhibition of Ser/Thr phosphatases will lead to Akt activation. The major Ser/Thr protein phosphatases in mammalian cells are PP1, PP2A, and PP2B (10) . In this study, we focused on the role of PP2A and found that exogenous zinc was able to decrease PP2A activity, which may result in upregulation of Akt activity. We further demonstrated that inhibition of Ser/Thr protein phosphatases with calyculin A also mimicked the effect of zinc to activate Akt, reinforcing the critical role of PP2A in Akt activation. These findings suggest that in addition to IGF-1RTK, Ser/Thr protein phosphatases may also play a role in zinc-induced Akt activation. However, it should be mentioned that more studies are needed to characterize the exact role of Ser/Thr protein phosphatases in the action of zinc. In addition, it would be interesting to investigate the precise molecular mechanism by which zinc inhibits Ser/Thr protein phosphatases.
In summary (Fig. 8) , exogenous zinc upregulates Akt activity by activating IGF-1RTK and prevents the mPTP opening in cardiac cells. Inactivation of Ser/Thr protein phosphatases may also contribute to zinc-induced Akt activation. Zinc may not rapidly regulate PTEN activity.
GRANTS
This work was supported by National Heart, Lung, and Blood Institute Grant R01-HL-08336.
